LINKFAR Debuts Its Full Patch Portfolio at EASD 2026 in Milan

LINKFAR Healthcare GmbH, a Germany-based medical-device company, joined the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan from 28 September to 2 October 2026. At Booth F.10, we reached a particular milestone: the first complete presentation of LINKFAR's CGM and insulin pump adhesive patch portfolio at a specialist European diabetes exhibition.

For us, this was more than adding another product display to the booth. It was an opportunity to show how patch materials, shapes and application details can be organised as a coherent product line for diabetes-care distributors, device partners and private-label projects.

A full portfolio means more than more colours

The portfolio brought together nylon, nonwoven, cotton and PU-film constructions, alongside different shapes and centre designs developed around common CGM and insulin pump formats. Each construction starts with a different set of practical questions: how the patch feels, how it follows body contours, how visible it is, how it behaves around moisture and movement, and how it fits the intended device.

That distinction matters. A patch that works well for one sensor geometry or wearing situation is not automatically the best choice for another. The finished construction—including backing, adhesive, coating, opening, edge profile and release liner—has to be considered as a system.

A complete patch portfolio is not one universal patch offered in many colours. It is a set of material and geometry choices built around different devices, wearing situations and channel needs.

Why EASD was the right place for the debut

A specialist diabetes meeting changes the conversation. Visitors were not only asking whether a patch could help secure a device. They wanted to compare materials, understand the purpose of different openings and shapes, discuss skin-contact considerations and consider which assortment would make sense for their market.

Those discussions also went beyond the overpatch itself. Distributors and product partners need clear model identification, packaging, user information and a practical way to explain the differences between products. For OEM and private-label development, device dimensions, target users, wearing environment, preferred material and commercial channel all need to be defined before a sample can be evaluated properly.

The strong response in Milan came through detailed, sustained conversations around these questions. Rather than treating patches as a generic accessory, visitors examined them as a product category with its own material choices, fitting logic and user-experience trade-offs. That is exactly the discussion we hoped to open.

Developed for Europe, supported from Germany

For selected LINKFAR-branded CGM and insulin pump adhesive patch products, LINKFAR Healthcare GmbH acts as the legal manufacturer. For suitable projects involving products manufactured outside the EU, we can also discuss acting as the EU importer. The applicable economic-operator role is confirmed for the individual product and supply route; it is not a blanket claim for every item shown at the exhibition.

This Germany-based structure gives distributors and project partners a local European contact for material and device-format selection, sample coordination, private-label development, packaging and labelling, document review, importer-role assessment, German entry and onward-delivery planning, and the routing of complaints and market feedback. The exact service scope is agreed before a project begins.

From a patch range to a clearer choice

LINKFAR's objective is not to claim that one construction solves every wearing challenge. Our aim is to give professional buyers a clearer basis for selecting and developing products:

  • material choices for different feel, visibility and everyday-use priorities;
  • device-oriented shapes and centre constructions;
  • product and packaging options for distribution and private-label programmes;
  • supporting accessories that can be considered as part of a wider CGM or pump-wear routine.

The feedback from EASD will continue to inform how we organise samples, product education and development discussions. It also confirmed that buyers value a supplier who can explain why two patches are different—not simply show that both are available.

Thank you to everyone who visited LINKFAR at Booth F.10 in Milan. The official EASD 2026 page confirms the meeting dates and venue. To explore the wider category, visit our CGM and insulin pump accessories guide, read our guide to CGM patch materials, adhesives and quality, view the CGM and pump patch product range, review our OEM and European market-support services, learn how we distinguish EU importer and distributor responsibilities, or contact LINKFAR to discuss samples, distribution or a defined project.

Related guides

Read more articles

Share your love